Bangladesh must prioritise the domestic production of active pharmaceutical ingredients (APIs) to secure a strong foothold in the global export market and mitigate potential challenges after ...
The COVID-19 pandemic exposed significant vulnerabilities in global pharmaceutical supply chains, particularly regarding the availability of active pharmaceutical ingredients (APIs)—the essential ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results